Arrow Electronics, Inc. Common Stock (ARW)

Cost of Revenue

$31.90B

TTM · Period ending: · USD

ARW logo

ARW Cost of Revenue

Latest reported$31.90B
ARW TTM Cost of Revenue ($0.00 → $31.90B)
High-resolution chart · PNG

ARW cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arrow Electronics, Inc. Common Stock Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
31,901,070,000
29,765,332,000
27,386,216,000
26,128,109,000
25,289,373,000
24,604,507,000
24,630,916,000
25,010,956,000
25,999,887,000
27,401,930,000
28,958,102,000
30,215,523,000
31,267,621,000
32,043,782,000
32,287,797,000
31,990,468,000
31,347,567,000
30,685,465,000
30,274,653,000
29,985,460,000
28,991,511,000
27,285,016,000
25,482,233,000
24,466,974,000
24,303,581,000
24,977,189,000
25,618,466,000
26,046,031,000
26,333,421,000
26,263,490,000
25,975,856,000
25,736,786,000
25,280,501,000
24,462,173,000
23,455,169,000
22,370,970,000
21,423,518,000
20,955,448,000
20,681,062,000
20,973,895,000
20,766,902,000
20,654,986,000
20,246,770,000
19,915,414,000
19,844,006,000
19,711,630,000
19,772,779,000
19,557,494,000
19,049,516,000
18,737,011,000
18,566,356,000
17,896,482,000
17,819,543,000
17,666,449,000
17,667,842,000
17,667,645,000
17,843,751,000
18,150,116,000
18,441,661,000
18,300,755,000
17,874,084,000
17,129,131,000
16,326,069,000
15,477,653,000
14,679,410,000
13,644,208,000
12,933,207,000
12,796,496,000
13,277,151,000
14,022,528,000
14,478,296,000
14,713,528,000
14,459,875,000
14,183,982,000
13,699,715,000
12,876,829,000
12,345,237,000
11,798,732,000
11,545,719,000
11,076,560,000
10,421,258,000
9,834,864,000
9,424,586,000
9,034,752,000
8,992,378,000
8,965,366,000
8,922,962,000
8,893,574,000
8,396,716,000
7,865,550,000
7,258,360,000
6,738,892,000
6,489,929,000
6,245,622,000
6,232,444,000
6,477,046,000
6,925,487,000
7,513,853,000
8,609,448,000
9,892,870,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.